期刊文献+

心肌标志物联合检测在ACS诊断中的应用

心肌标志物联合检测在ACS诊断中的应用
下载PDF
导出
摘要 目的心肌标志物联合检测在ACS诊断中的意义。方法对40例胸痛患者在发病后即刻及入院后6小时、12小时、24小时、48小时检测心肌损伤标志物肌钙蛋白(CTni.CTnt)肌红蛋白(MYO)和肌酸肌酶同工酶(CK-MB)。结果40例胸痛患者心肌标志物联合检测对明确不稳定性心绞痛、急性心肌梗死、非心肌缺血性胸痛具有重要的临床意义。结论心肌标志物联合检测在不同时期对诊断ACS有重要的临床指导意义。 Objective Cardic muscle sign union examination in ACS diagnosissignificance. Methods Instantly and is hospitalized latter 6 hours,12 hours, 24 hours, 48 hours examinations cardic muscle to 40 exampleschest pain patient after arising damages the sign CTni the MYO and the CK-MB. Results 40 examples chest pain patient cardic muscle sign unionexamination to is clear about the unstable angina pectoris, the acut myocardial infarction, the non-cardic muscle lacks the courage anduprightness chest pain to have the vital clinical significance. Conclusion Cardic muscle sign union examination to diagnoses ACS inthe different time to have the important clinical instructionsignificance.
作者 严锋 蒋屹山
出处 《医学动物防制》 2007年第11期871-872,共2页 Journal of Medical Pest Control
关键词 心肌损伤标志物 急性冠状动脉综和征 不稳定性心绞痛 急性心肌梗死 The cardic muscle damages the sign acute coronary
  • 相关文献

参考文献4

  • 1李甲芬.心肌标志物的应用[G].全国心血管病实验室诊断与临床专题学术研讨会论文汇编(2007年5月.济南),188.
  • 2许俊堂,胡大一.心肌标志物与急性冠状动脉综合征[G].全国心血管病实验室诊断与临床专题学术研讨会论文汇编(2007年5月.济南),13.
  • 3诸俊仁.重度心肌标志物的研究进展和临床应用.上海医学检验,2002,15:23-23.
  • 4潘柏申.心肌损伤标志物的研究进展与心肌梗死诊断标准的修订[J].临床检验杂志,2002,20(3):129-132. 被引量:139

二级参考文献44

  • 1[1]Wu A H B. Biochemical markers of cardiac damage: from traditional enzymes to cardiac-specific proteins[J]. Scand J Clin Lab Invest,1999,59(Suppl 230): 74-82.
  • 2[2]Panteghni M, Apple F S, Christenson R H, et al. Proposal from IFCC committee on Standadization of Markers of Cardiac Damage (C-SMCD): recommendation on use of biochemical markers of cardiac damage in acute coronary syndromes [J]. Scand J Clin Lab Invest, 1999,59(Suppl 230): 103-112.
  • 3[3]Wu A H,Apple F S ,Gibler W B, et al. National Academy of Clinical Biochemistry Standards of Laboratory Practice: recommendations for the use of cardiac markers in coronary artery disease[J]. Clin Chem,1999,45: 1104-1121.
  • 4[4]Alpert J S, Thygesen K, Antman E, et al. Myocardial infarction redefined:a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction[J]. J Am Coll Cardiol, 2000,36: 959-969.
  • 5[5]Giri S,Waters D D,Wu A H B. Pathophysiology of acute coronary syndromes In: Card iac markers. Ed. Wu A H B. New Jersey:Humana Press Inc, 1998.21-44.
  • 6[6]Winter R J, Fischer J, Bholasingh R, et al. C-reactive protein and cardiac troponin T in risk stratification:differences in optimal timing of tests early after the onset of chest pain[J]. Clin Chem,2000,46:1597-1603.
  • 7[7]Koenig W, Sund M, Frohlich M, et al. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary, heart disease in initial healthy middle-aged men: results from the MONICA Augsburg Cohort Study, 1984 to 1992 [J]. Circulation, 1999, 99:237-242.
  • 8[8]Zimmerman J, Fromm R, Meyer D, et al. Diagnostic marker cooperative study for the diagnosis of myocardial infarction [J].Circulation, 1999,99: 1671-1677.
  • 9[9]Roberts W T, Sedrick R, Moulton L, et al. Evaluation of four automated high-sensitivity C-reactive protein methxts: implications for clinical and epidemiological applications[J]. Clin Chem, 2000,46:461-468.
  • 10[10]Rifai N, Ridker P M. High-sensitivity C-reactive protein: a novel and promising marker of coronary heart disease [J]. Clin Chem,2001,47: 403-411.

共引文献139

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部